Apiam Animal Health Limited

CHIA:AHX Stock Report

Market Cap: AU$73.0m

Apiam Animal Health Past Earnings Performance

Past criteria checks 4/6

Apiam Animal Health's earnings have been declining at an average annual rate of -0.01%, while the Healthcare industry saw earnings declining at 3.3% annually. Revenues have been growing at an average rate of 14.5% per year. Apiam Animal Health's return on equity is 4%, and it has net margins of 2.4%.

Key information

-0.008%

Earnings growth rate

-10.5%

EPS growth rate

Healthcare Industry Growth2.4%
Revenue growth rate14.5%
Return on equity4.0%
Net Margin2.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Apiam Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CHIA:AHX Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24205500
31 Mar 24204400
31 Dec 23202300
30 Sep 23197200
30 Jun 23192200
31 Mar 23184400
31 Dec 22176600
30 Sep 22166500
30 Jun 22157500
31 Mar 22149400
31 Dec 21140410
30 Sep 21133510
30 Jun 21126520
31 Mar 21125520
31 Dec 20123520
30 Sep 20121520
30 Jun 20118420
31 Mar 20115420
31 Dec 19112320
30 Sep 19112320
30 Jun 19112320
31 Mar 19112320
31 Dec 18112320
30 Sep 18109320
30 Jun 18107320
31 Mar 18105310
31 Dec 17103410
30 Sep 17100410
30 Jun 1798510
31 Mar 1794520
31 Dec 1690520
30 Sep 1672320
30 Jun 1654010

Quality Earnings: AHX has high quality earnings.

Growing Profit Margin: AHX's current net profit margins (2.4%) are higher than last year (1.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AHX's earnings have declined by 0.01% per year over the past 5 years.

Accelerating Growth: AHX's earnings growth over the past year (116.6%) exceeds its 5-year average (-0.01% per year).

Earnings vs Industry: AHX earnings growth over the past year (116.6%) exceeded the Healthcare industry -25.4%.


Return on Equity

High ROE: AHX's Return on Equity (4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 08:28
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apiam Animal Health Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Louis BannonCCZ Equities Pty Limited
Jonathon HigginsShaw and Partners Limited